Evaluation of the change in sphingolipids in the human multiple myeloma cell line U266 and gastric cancer cell line MGC-803 treated with arsenic trioxide

Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MS

B.K. Matuszewski, M.L. Constanzer, C.M. Chavez-Eng · Analytical Chemistry · 2003 · 5.2K citations

Pharmacy, Pharmaceutical Analysis, Pharmacokinetics +17

Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

Zhixiang Shen, Guoqiang Chen, Jian-Hua Ni et al. · Blood · 1997 · 1.4K citations

Medicine, Pharmacokinetics, Pharmacology +17

Mechanisms of action of arsenic trioxide.

Wilson H. Miller, Hyman M. Schipper, Janet Lee et al. · PubMed · 2002 · 956 citations

Medicine, Hematology, Oncology +17

Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway

Valérie Lallemand-Breitenbach, Marion Jeanne, Shirine Benhenda et al. · Nature Cell Biology · 2008 · 715 citations

Life Sciences, Cell Biology, Molecular Biology +9

Sphingolipidomics: High-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry

Alfred H. Merrill, M. Cameron Sullards, Jeremy C. Allegood et al. · Methods · 2005 · 600 citations

Life Sciences, Biochemistry, Molecular Biology +14